- Conditions
- Type 1 Diabetes, Monogenic Diabetes
- Interventions
- Metformin Extended Release Oral Tablet, Sitagliptin
- Drug
- Lead sponsor
- Joslin Diabetes Center
- Other
- Eligibility
- Up to 85 Years
- Enrollment
- 3 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2024
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Feb 23, 2025 · Synced May 22, 2026, 5:23 AM EDT